Bleakley Financial Group, LLC

SEC CIK: 0001936953
Latest filing: Aug 5, 2026

SEC filings (opens in a new tab)

KALV holding history

KalVista Pharmaceuticals, Inc. in every 13F filed by Bleakley Financial Group, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

KALV overview All 13F holders of KALV Full Q2 2026 holdings

Shares (Q2 2026): 0; Sold out in Q2 2026
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q4 2025

Holdings of KALV by Bleakley Financial Group, LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	0	$0	0.0%	−12,954−100.0%	Sold out	Holders
Q1 2026	12,954	$260.8K	<0.1%	−3,022−18.9%	Reduced	Holders
Q4 2025	15,976	$258.0K	<0.1%	+15,976	New	Holders